Characterization of a novel plasmid type and various genetic contexts of blaOXA-58 in Acinetobacter spp. from multiple cities in China

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Fu, Yiqi ^a   Jiang, Jingjin ^a   Zhou, Hua ^a   Jiang, Yan ^b   Fu, Ying ^b   Yu, Yunsong ^b   Zhou, Jianying ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM; CARBAPENEMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; MEROPENEM; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TICARCILLIN;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER NOSOCOMIALIS; ACINETOBACTER PITTII; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BLAOXA-23 GENE; BLAOXA-58 GENE; CHINA; CLONE; ELECTROTRANSFORMATION; GENE INSERTION SEQUENCE; GENE LOCATION; MOLECULAR EPIDEMIOLOGY; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; REPLICON;

ACINETOBACTER; ACINETOBACTER INFECTIONS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CHINA; CITIES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; PLASMIDS;

EID: 84896997393     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084680     Document Type: Article

References (35)

1. Peleg AY, Seifert H, Paterson DL (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21: 538-582.
2. Karageorgopoulos DE, Falagas ME (2008) Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 8: 751-762.
3. Woodford N, Turton JF, Livermore DM (2011) Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 35: 736-755.
4. Poirel L, Marque S, Heritier C, Segonds C, Chabanon G, et al. (2005) OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 49: 202-208. (Pubitemid 40065794)
5. Coelho J, Woodford N, Afzal-Shah M, Livermore D (2006) Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob Agents Chemother 50: 756-758. (Pubitemid 43190994)
6. Peleg AY, Franklin C, Walters LJ, Bell JM, Spelman DW (2006) OXA-58 and IMP-4 carbapenem-hydrolyzing β-lactamases in an Acinetobacter junii blood culture isolate from Australia. Antimicrob Agents Chemother 50: 399-400. (Pubitemid 43042958)
7. Castanheira M, Wanger A, Kruzel M, Deshpande LM, Jones RN (2008) Emergence and clonal dissemination of OXA-24- and OXA-58-producing Acinetobacter baumannii strains in Houston, Texas: report from the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol 46: 3179-3180.
8. Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN (2009) Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother 63: 55-59.
9. OXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother 50: 1442-1448.
10. OXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii. Antimicrob Agents Chemother 52: 2573-2580.
11. OXA-58 gene with its hybrid promoter provided by IS1006 and an ISAba3-like element to beta-lactam resistance in acinetobacter genomic species 13TU. Antimicrob Agents Chemother 54: 3107-3112.
12. Marti S, Sanchez-Cespedes J, Blasco MD, Ruiz M, Espinal P, et al. (2008) Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate. Antimicrob Agents Chemother 52: 2955-2958.
13. OXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 53: 843-844.
14. Marti S, Sanchez-Cespedes J, Blasco MD, Espinal P, Ruiz M, et al. (2008) Characterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an Acinetobacter phenon 6/ct13TU clinical isolate. Diagn Microbiol Infect Dis 61: 468-470. (Pubitemid 351982005)
15. Towner KJ, Evans B, Villa L, Levi K, Hamouda A, et al. (2011) Distribution of intrinsic plasmid replicase genes and their association with carbapenem-hydrolyzing class D β-lactamase genes in European clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 55: 2154-2159.
16. Wang H, Guo P, Sun H, Yang Q, Chen M, et al. (2007) Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother 51: 4022-4028. (Pubitemid 350057801)
17. Zhou H, Yang Q, Yu YS, Wei ZQ, Li LJ (2007) Clonal spread of imipenem-resistant Acinetobacter baumannii among different cities of China. J Clin Microbiol 45: 4054-4057. (Pubitemid 350274894)
18. Chang HC, Wei YF, Dijkshoorn L, Vaneechoutte M, Tang CT, et al. (2005) Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region. J Clin Microbiol 43: 1632-1639.
19. Adams-Haduch JM, Paterson DL, Sidjabat HE, Pasculle AW, Potoski BA, et al. (2008) Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob Agents Chemother 52: 3837-3843.
20. Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H (2009) OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 53: 5035-5038.
21. Chen Y, Zhou Z, Jiang Y, Yu Y (2011) Emergence of NDM-1-producing Acinetobacter baumannii in China. J Antimicrob Chemother 66: 1255-1259.
22. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
23. Bartual SG, Seifert H, Hippler C, Luzon MA, Wisplinghoff H, et al. (2005) Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J Clin Microbiol 43: 4382-4390. (Pubitemid 41298217)
24. Fu Y, Zhou J, Zhou H, Yang Q, Wei Z, et al. (2010) Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. J Antimicrob Chemother 65: 644-650.
25. Barton BM, Harding GP, Zuccarelli AJ (1995) A general method for detecting and sizing large plasmids. Anal Biochem 226: 235-240.
26. Bertini A, Poirel L, Mugnier PD, Villa L, Nordmann P, et al. (2010) Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother 54: 4168-4177.
27. He C, Xie Y, Fan H, Kang M, Tao C, et al. (2011) Spread of imipenem-resistant Acinetobacter baumannii of European clone II in Western China. Int J Antimicrob Agents 38: 257-260.
28. D'Arezzo S, Capone A, Petrosillo N, Visca P, Ballardini M, et al. (2009) Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy). Clin Microbiol Infect 15: 347-357.
29. Gogou V, Pournaras S, Giannouli M, Voulgari E, Piperaki ET, et al. (2011) Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09). J Antimicrob Chemother 66: 2767-2772.
30. Zhang JP, Zhu W, Tian SF, Chu YZ, Chen BY (2010) Molecular characteristics and resistant mechanisms of imipenem-resistant Acinetobacter baumannii isolates in Shenyang, China. J Microbiol 48: 689-694.
31. Martin P, Jullien E, Courvalin P (1988) Nucleotide sequence of Acinetobacter baumannii aphA-6 gene: evolutionary and functional implications of sequence homologies with nucleotide-binding proteins, kinases and other aminoglycoside-modifying enzymes. Mol Microbiol 2: 615-625.
32. Nigro SJ, Post V, Hall RM (2011) Aminoglycoside resistance in multiply antibiotic-resistant Acinetobacter baumannii belonging to global clone 2 from Australian hospitals. J Antimicrob Chemother 66: 1504-1509.
33. OXA-23-like genes in carbapenem-susceptible Acinetobacter clinical isolates: should we be concerned? J Med Microbiol 58: 839-841.
34. OXA-58 expression in Acinetobacter baumannii. Antimicrob Agents Chemother 55: 917-920.
35. OXA-58 genes in Acinetobacter genospecies 3. J Antimicrob Chemother 65: 1586-1588.